Testing an experimental virus therapy, G207, in children with cerebellar brain tumors that came back or kept growing
Original title: HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test in a small number of people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing whether an experimental virus therapy is safe for children whose cerebellar brain tumor has come back or has not responded to treatment.
Who this trial is for. This trial is for children with a brain tumor in the cerebellum that has come back or has not responded to treatment. The study puts an experimental virus therapy called G207 into the tumor. It also tests giving G207 with a single low dose of radiation, which is meant to help the virus copy itself, kill tumor cells, and stir up the immune system against the tumor.
Where it stands. There are no results to share. The trial is looking at whether this treatment is safe, both on its own and with the low dose of radiation. The source does not report any findings yet. So we do not know if it helps.
What this means, and what it doesn't
What it could mean: This is one of the ways new treatments get tested in children. If your child fits this picture, you could ask your care team about it. They can tell you if it makes sense for your child and what the trial team would need to know.
What it doesn't mean: This does not mean G207 works. A trial is a test, not a proven treatment. Joining a study does not guarantee any benefit, and it can carry risks. This is not a promise of a cure. Nothing here says your child can join. The trial team decides who takes part.
Source: ClinicalTrials.gov, July 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.